Opportunities for Aligning Prescription Drug Affordability Boards and Cost-Growth Benchmarks
NASHP
NOVEMBER 15, 2021
In states such as Massachusetts, there is also a threat of a targeted performance improvement plan for entities determined to be cost drivers. Engagement of Stakeholders: PDABs and cost-growth benchmarks create a forum for convening and holding accountable the stakeholders involved in the high costs of health care.
Let's personalize your content